M2 proton channel inhibitors (Ambrilia Biopharma)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameM2 proton channel inhibitors (Ambrilia Biopharma)
Drug Alias Nameinfluenza A virus M2 protein inhibitors
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMatrix protein 2 inhibitors
TargetsMatrix protein 2
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmbrilia Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbrilia Biopharma Inc
Active IndicationsN/A
Inactive IndicationsInfluenza A virus infections

Other Information

ATC CodeN/A
Related LinksN/A